Source: StreetInsider

Press Release: Paradigm : Paradigm Diagnostics Receives Expanded Medicare Coverage for PCDx for Solid Tumors

PHOENIX, Jan. 10, 2020 /PRNewswire/ --Â Paradigm Diagnostics, Inc. announced that Palmetto GBA, the Medicare Administrative Contractor (MAC) for the Molecular Diagnostics MolDX program, has reviewed the technical dossier and broadly approved the...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
David Mallery's photo - Chairman & CEO of Paradigm Diagnostics, Inc.

Chairman & CEO

David Mallery

CEO Approval Rating

89/100

Read more